Related references
Note: Only part of the references are listed.COVID-19 vaccines: where we stand and challenges ahead
Guido Forni et al.
CELL DEATH AND DIFFERENTIATION (2021)
Optimism and caution for an inactivated COVID-19 vaccine
Christina A. Rostad et al.
LANCET INFECTIOUS DISEASES (2021)
China COVID vaccine reports mixed results — what does that mean for the pandemic?
Smriti Mallapaty
NATURE (2021)
Critical aspects of packaging, storage, preparation, and administration of mRNA and adenovirus-vectored COVID-19 vaccines for optimal efficacy
Gregory A. Poland
VACCINE (2021)
Anticipation of COVID-19 vaccines reduces willingness to socially distance
Ola Andersson et al.
JOURNAL OF HEALTH ECONOMICS (2021)
Risk Compensation and COVID-19 Vaccines
Brit Trogen et al.
ANNALS OF INTERNAL MEDICINE (2021)
CHINA'S COVID VACCINES HAVE BEEN CRUCIAL - NOW IMMUNITY IS WANING
Smriti Mallapaty
NATURE (2021)
Effectiveness of BNT162b2 Vaccine against Delta Variant in Adolescents
Ben Y. Reis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
Noa Dagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Effectiveness of Messenger RNA Coronavirus Disease 2019 (COVID-19) Vaccines Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in a Cohort of Healthcare Personnel
Melanie D. Swift et al.
CLINICAL INFECTIOUS DISEASES (2021)
Waning immunity to SARS-CoV-2: implications for vaccine booster strategies
Daniel M. Altmann et al.
LANCET RESPIRATORY MEDICINE (2021)
Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data
Eric J. Haas et al.
LANCET (2021)
Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study
Sam Moore et al.
LANCET INFECTIOUS DISEASES (2021)
Covid-19: What do we know about Sputnik V and other Russian vaccines?
Chris Baraniuk
BMJ-BRITISH MEDICAL JOURNAL (2021)
What do we know about China's covid-19 vaccines?
Chris Baraniuk
BMJ-BRITISH MEDICAL JOURNAL (2021)
What do we know about India's Covaxin vaccine?
Kamala Thiagarajan
BMJ-BRITISH MEDICAL JOURNAL (2021)
Interim Estimates of Vaccine Effectiveness of Pfizer-BioNTech and Moderna COVID-19 Vaccines Among Health Care Personnel-33 US Sites, January-March 2021
Tamara Pilishvili et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Effect of 2 Inactivated SARS-CoV-2 Vaccines on Symptomatic COVID-19 Infection in Adults A Randomized Clinical Trial
Nawal Al Kaabi et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile
Alejandro Jara et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
Mark G. Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Estimating Relative Risk When Observing Zero Events-Frequentist Inference and Bayesian Credibility Intervals
Soeren Moeller et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
Effectiveness of COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Frontline Workers Before and During B.1.617.2 (Delta) Variant Predominance — Eight U.S. Locations, December 2020–August 2021
Ashley Fowlkes et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)
Transmission, viral kinetics and clinical characteristics of the emergent SARS-CoV-2 Delta VOC in Guangzhou, China
Yaping Wang et al.
ECLINICALMEDICINE (2021)
Preparing for COVID-19 exit strategies
Michelle Griffin et al.
ANNALS OF MEDICINE AND SURGERY (2021)
Feasibility of Using Real-World Data to Replicate Clinical Trial Evidence
Victoria L. Bartlett et al.
JAMA NETWORK OPEN (2019)
Good practices for real-world data studies of treatment and/or comparative effectiveness: Recommendations from the joint ISPOR-ISPE Special Task Force on real-world evidence in health care decision making
Marc L. Berger et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2017)
Sensitivity Analysis in Observational Research: Introducing the E-Value
Tyler J. VanderWeele et al.
ANNALS OF INTERNAL MEDICINE (2017)
Computing adjusted risk ratios and risk differences in Stata
Edward C. Norton et al.
STATA JOURNAL (2013)
What's the Risk? A Simple Approach for Estimating Adjusted Risk Measures from Nonlinear Models Including Logistic Regression
Lawrence C. Kleinman et al.
HEALTH SERVICES RESEARCH (2009)
Methods for estimating adjusted risk ratios
Peter Cummings
STATA JOURNAL (2009)